Pàgina inicial > Resultats de la cerca: Farge, D.
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 4 registres trobats en 0.01 segons.
Articles, 4 registres trobats
Articles 4 registres trobats  
1.
10 p, 839.2 KB Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism : The RIETECAT study / Trujillo-Santos, Javier (Hospital General Universitario Santa Lucía (Cartagena, Múrcia)) ; Farge-Bancel, Dominique (Université de Paris) ; Pedrajas, José María (Hospital Clínico San Carlos (Madrid)) ; Gómez-Cuervo, Covadonga (Hospital 12 de Octubre (Madrid)) ; Ballaz, Aitor (Hospital de Galdakao (Usansolo, Biscaia)) ; Braester, Andrei (Bar-Ilan University) ; Mahé, Isabelle (Hôpital Louis Mourier) ; Villalobos, Aurora (Hospital Regional Universitario de Málaga) ; Porras, José Antonio (Hospital Universitari Joan XXIII de Tarragona) ; Monreal, Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
Venous thromboembolism (VTE) is a frequent complication in patients with cancer and a leading cause of morbidity and death. The objective of the RIETECAT study was to compare the long-term effectiveness and safety of enoxaparin versus dalteparin or tinzaparin for the secondary prevention of VTE in adults with active cancer. [...]
2022 - 10.1002/rth2.12736
Research and Practice in Thrombosis and Haemostasis, Vol. 6 (june 2022)  
Registre complet - Creative Commons
2.
10 p, 1.3 MB General information for patients and carers considering haematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (ADs) : A position statement from the EBMT Autoimmune Diseases Working Party (ADWP), the EBMT Nurses Group, the EBMT Patient, Family and Donor Committee and the Joint Accreditation Committee of ISCT and EBMT (JACIE) / Jessop, Helen (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Farge, Dominique (McGill University) ; Saccardi, Riccardo (Careggi University Hospital (Florència, Itàlia)) ; Alexander, Tobias (Charité - Universitätsmedizin Berlin) ; Rovira Tarrats, Montserrat (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Sharrack, Basil (University of Sheffield) ; Greco, Raffaella (San Raffaele Scientific Institute) ; Wulffraat, Nico (Wilhelmina Kinderziekenhuis) ; Moore, John (St Vincent's Hospital (Sydney)) ; Kazmi, Majid (King's College Hospital NHS Foundation Trust) ; Badoglio, Manuela (EBMT Paris study office) ; Adams, Geert (EBMT Executive Office) ; Verhoeven, Bregje (EBMT Executive Office) ; Murray, John (Christie Hospital NHS Foundation Trust) ; Snowden, John A (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Universitat Autònoma de Barcelona
Over the last 20 years, haematopoietic stem cell transplantation (HSCT) has been used to treat patients with severe autoimmune and inflammatory diseases whose response to standard treatment options has been limited, resulting in a poor long-term prognosis in terms of survival or disability. [...]
2019 - 10.1038/s41409-019-0430-7
Bone marrow transplantation, Vol. 54 Núm. 7 (january 2019) , p. 933-942  
Registre complet - Creative Commons
3.
24 p, 2.3 MB Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases : updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE) / Sharrack, Basil (NIHR Neurosciences Biomedical Research Centre. University of Sheffield) ; Saccardi, Riccardo (Careggi University Hospital (Florència, Itàlia)) ; Alexander, Tobias (Charité - Universitätsmedizin Berlin) ; Badoglio, Manuela (EBMT Paris study office. Department of Haematology. Saint Antoine Hospital. INSERM UMR 938. Sorbonne University) ; Burman, Joachim (Department of Neuroscience. Uppsala University) ; Farge-Bancel, Dominique (EA 3518. Université Denis Diderot) ; Greco, Raffaella (IRCCS San Raffaele Scientific Institute (Milà, Itàlia). Hematology and Bone Marrow Transplantation Unit) ; Jessop, Helen (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Kazmi, Majid (King's College Hospital NHS Foundation Trust) ; Kirgizov, Kirill Igorevich (N.N. Blokhin National Medical Center of Oncology. Institute of Pediatric Oncology and Hematology) ; Labopin, Myriam (EBMT Paris study office. Department of Haematology. Saint Antoine Hospital. INSERM UMR 938. Sorbonne University) ; Mancardi, Giovanni Luigi (University of Genova and Clinical Scientific Institutes Maugeri. Department of Neuroscience) ; Martin, Roland (University Hospital Zurich (Suïssa)) ; Moore, John (St. Vincent's Health Network. Haematology Department.) ; Muraro, Paolo Antonio (Imperial College London) ; Rovira Tarrats, Montserrat (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Sormani, Maria Pia (IRCCS Ospedale Policlinico San Martino) ; Snowden, John A. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Snowden, John A (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; McGrath, Eoin (EBMT Executive Office) ; Bambi, Franco (Ospedale Pediatrico. Azienda Ospedaliero Universitaria Meyer (A.O.U. Meyer)) ; Sanchez-Guijo, Fermin (Instituto de Investigación Biomédica de Salamanca) ; Worel, Nina (Blood Group Serology and Transfusion Medicine. Medical University of Vienna) ; Abinun, Mario (Great North Children's Hospital. Institute of Cellular Medicine. Newcastle University) ; Arnold, Renate (Charité - Universitätsmedizin Berlin) ; Brierley, Charlotte (Oxford University Hospitals NHS Foundation Trust) ; Castilla-Llorente, Cristina (Unité de transplantation des cellules souches. Département d'Hématologie Gustave Roussy) ; Cooper, Nichola (Hammersmith Hospital (Londres)) ; Daikeler, Thomas D. (University Hospital Basel (Basilea, Suïssa)) ; del Papa, Nicoletta (Ospedale Gaetano Pini. Department of Rheumatology) ; Farge-Bancel, Dominique (EA 3518. Université Denis Diderot) ; Finke, Jürgen M. (Department of Medicine-Hematology and Oncology. University of Freiburg) ; Hagglund, Hans G. (Department of Hematology. Uppsala University Hospital) ; Henes, Jörg Christoph (University Hospital of Tübingen (Alemanya)) ; Hiepe, Falk (Charité - Universitätsmedizin Berlin) ; Kiely, David G. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Marjanovic, Z. (Department of Haematology. Saint Antoine Hospital) ; Martin, Roland (Neuroimmunology and MS Research. Neurology Clinic. University Hospital) ; Martin, Thierry (Department of Clinical Immunology. National Referral Center for Autoimmune Diseases. Strasbourg University Hospital) ; Ma, D. (Haematology Department. St. Vincent's Health Network) ; Moore, J. (Haematology Department. St. Vincent's Health Network) ; Miller, P. (Anthony Nolan Research Institute) ; Muraro, P. (Imperial College London) ; Oliveira, M. C. (Division of Clinical Immunology. Ribeirão Preto Medical School. University of São Paulo) ; Polushin, A. (Raisa Gorbacheva Memorial Research Institute for Pediatric Oncology. Hematology and Transplantation First State Pavlov Medical University of Saint Petersburg) ; Onida, F. (Haematology-BMT Centre. Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico. Università degli Studi di Milano) ; Simoes, B. (Division of Hematology. Ribeirão Preto Medical School. University of São Paulo) ; Puyade, M. (Centre Hospitalier Universitaire de Poitiers) ; Resnick, I. (University Hospital St. Marina) ; Rovira Argelagués, Montserrat (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Saccardi, R. (Careggi University Hospital (Florència, Itàlia)) ; Saif, M. (Department of Clinical Haematology. Manchester Royal Infirmary) ; Sakellari, Ioanna (Bone Marrow Transplantation Unit. George Papanicolaou General Hospital) ; Sharrack, B. (NIHR Neurosciences Biomedical Research Centre. University of Sheffield) ; Snarski, E. (Department of Hematology. Oncology and Internal Medicine. Medical University of Warsaw) ; Scherer, H. U. (Department of Rheumatology. Leiden University Medical Centre) ; Sossa, C. (Division of Hematology and Hematopoietic Stem Cell Transplantation. Hematology and Stem Cell Transplantation Unit. Clinica FOSCAL) ; de Vries-Bouwstra, J. (Department of Rheumatology. Leiden University Medical Centre) ; Wulffraat, N. (Divisie Kinderen. Cluster Immunologie. Reumatologie. Hematologie en Infectiologie. Wilhelmina Kinderziekenhuis) ; Zaccara, E. (Osp. G. Pini. Department of Rheumatology) ; Universitat Autònoma de Barcelona
These updated EBMT guidelines review the clinical evidence, registry activity and mechanisms of action of haematopoietic stem cell transplantation (HSCT) in multiple sclerosis (MS) and other immune-mediated neurological diseases and provide recommendations for patient selection, transplant technique, follow-up and future development. [...]
2020 - 10.1038/s41409-019-0684-0
Bone marrow transplantation, Vol. 55 Núm. 2 (january 2020) , p. 283-306  
Registre complet - Creative Commons
4.
10 p, 421.6 KB Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism / Farge, Dominique (Assistance publique - Hôpitaux de Paris (França)) ; Trujillo-Santos, Javier (Hospital General Universitario Santa Lucía (Cartagena, Múrcia)) ; Debourdeau, Philippe (Institut Sainte Catherine (Avignon, França)) ; Bura-Riviere, Alessandra (Hôpital Rangueil (Toulouse, França)) ; Rodriguez-Beltrán, Eva María (Hospital Nuestra Señora de Sonsoles (Àvila)) ; Nieto, José Antonio (Hospital Virgen de La Luz (Cuenca)) ; Peris, María Luisa (Consorci Hospitalari Provincial de Castelló) ; Zeltser, David (Tel Aviv Sourasky Medical Center (Israel)) ; Mazzolai, Lucia (Centre Hospitalier Universitaire Vaudois (Lausanne, Suïssa)) ; Hij, Adrian (Assistance publique - Hôpitaux de Paris (França)) ; Monreal, Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; RIETE Investigators
In cancer patients treated for venous thromboembolism (VTE), including deep-vein thrombosis (DVT) and pulmonary embolism (PE), analyzing mortality associated with recurrent VTE or major bleeding is needed to determine the optimal duration of anticoagulation. [...]
2015 - 10.1097/MD.0000000000001235
Medicine, Vol. 94 Núm. 32 (august 2015)  
Registre complet - Creative Commons

Vegeu també: autors amb noms similars
2 Farge, Dominique
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem